SEARCH

SEARCH BY CITATION

Literature Cited

  • 1
    Centers for Disease Control US Department of Health and Human Sciences: Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Ann Intern Med 105: 234237, 1986.
  • 2
    Fahey JL, Taylor JMG, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 322: 166172, 1990.
  • 3
    Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, King D, The AZT Collaborative Working Group: The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double-blind, placebo-controlled trial. N Engl J Med 317: 185191, 1987.
  • 4
    Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, Wong B, Merigan TC, McAuliffe VJ, Hyslop NE, Rhamc FS, Balfour HH Jr., Spector SA, Volberding P, Pcttinelli C, Anderson J, The AIDS Clinical Trials Group: The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: A double-blind, placebo-controlled trial. Ann Intern Med 112: 727737, 1990.
  • 5
    Gelman R, Eudey L: Biostatistical considerations for quality assessment of immunologic measurements used in clinical and longitudinal studies. Clin Immunol Immunopathol 52: 2837, 1989.
  • 6
    Giorgi JV, Cheng H-L, Margolick JB, Bauer KD, Ferbas J, Waxdal M, Schmid I, Hultin LE, Jackson AL, Park L, Taylor JMG, The Multicenter AIDS Cohort Study Group: Quality control in the flow cytometric measurement of T-lymphocyte subsets: The multicenter AIDS cohort study experience. Clin Immunol Immunopathol 55: 173186, 1990.
  • 7
    Giorgi JV, Kesson AM, Chou C-C: Immunodeficiency and infectious diseases. In: Manual of Clinical Laboratory Immunology, 4th ed., RoseNR, de MacarioEC, FaheyJL, FriedmanH, PennGM (eds). American Society of Microbiology, Washington DC, 1992, pp 174181.
  • 8
    Harvath L: Quality control in clinical flow cytometry. Pathol Immunopathol Res 7: 338344, 1988.
  • 9
    Hoffman RA, Kung PC, Hansen WP, Goldstein G: Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci USA 77: 49144917, 1980.
  • 10
    Hultin LE, Hausner MA, Hultin PM, Giorgi JV: CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of T lymphocytes. Cytometry 1992, in press.
  • 11
    Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J, Winger E, Sacks HS, Hendrickson C, Moss A: Surrogate markers for survival in patients with AIDS-and AIDS related complex treated with zidovudine. Br Med J 302: 7378, 1991.
  • 12
    Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR: The Multicenter AIDS Cohort Study: Rationale, organization and selected characteristics of the participants. Am J Epidemiol 126: 310318, 1987.
  • 13
    Lambert JS, Seidlin M, Reichman RC, Plank CS, Laverty M, Morse GD, Knupp C, McLaren C, Pettinelli C, Valentine FT, Dolin R: 2′,3′-dideoxyinosine (ddl) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: A phase I trial. N Engl J Med 322: 13331339, 1990.
  • 14
    Landay A, Ohlsson-Wilhelm B, Giorgi JV: Application of flow cytometry to the study of HIV infection. AIDS 4: 479497, 1990.
  • 15
    Landay AL, Muirhead KA: Procedural guidelines for performing immunophenotyping by flow cytometry. Clin Immunol Immunopathol 52: 4860, 1989.
  • 16
    Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH: The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 136: 44804486, 1986.
  • 17
    Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF: Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 131: 17891796, 1983.
  • 18
    Loken MR, Brosnan JM, Bach BA, Ault KA: Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11: 453459, 1990.
  • 19
    Loken MR, Shah VO, Hollander Z, Civin CI: Flow cytometric analysis of normal B lymphoid development. Pathol Immunopathol Res 7: 357370, 1988.
  • 20
    Margolick JB, Carey V, Muñoz A, Polk BF, Giorgi JV, Bauer KD, Kaslow R, Rinaldo C: Development of antibodies to HIV-1 is associated with an increase in circulating CD3+ CD4– CD8– lymphocytes. Clin Immunol Immunopathol 51: 348361, 1989.
  • 21
    Margolick JB, Scott ER, Odaka N, Saah AJ: Flow cytometric analysis of γδ T cells and natural killer cells in HIV-1 infection. Clin Immunol Immunopathol 58: 126138, 1991.
  • 22
    Moss AR, Bacchetti P, Osmond D, Krampf W, Chaisson RE, Stites D, Wilber J, Allain J-P, Carlson J: Seropositivity for HIV and the development of AIDS or AIDS related condition: Three year follow up of the San Francisco General Hospital cohort. Br Med J 296: 745750, 1988.
  • 23
    National Committee for Clinical Laboratory Standards: Clinical Applications of Flow Cytometry: Quality Assurance and Immunophenotyping of Peripheral Blood Lymphocytes, Tentative Guidelines. NCCLS Publication H42-T, Villanova, PA, 1992.
  • 24
    Nishanian P, Taylor JMG, Korns E, Detels R, Saah A, Fahey JL: Significance of quantitative enzyme-linked immunosorbent assay (ELISA) results in evaluation of three ELISAs and Western blot tests for detection of antibodies to human immunodeficiency virus in a high-risk population. J Clin Microbiol 25: 395400, 1987.
  • 25
    Parker JW, Adelsberg B, Azen SP, Boone D, Fletcher MA, Gjerset GF, Hassett J, Kaplan J, Niland JC, Odom-Maryon T, Operskalski EA, Prince H, Scott D, Stites DP, Mosley JW, The Transfusion Safety Study Group: Leukocyte immunophenotyping by flow cytometry in a multisite study: Standardization, quality control and normal values in the transfusion safety study. Clin Immunol Immunopathol 55: 187220, 1990.
  • 26
    Paxton H, Kidd P, Landay A, Giorgi J, Plomenberg N, Walker E, Valentine F, Fahey J, Gelman R: Results of the flow cytometry ACTG quality control program: Analysis and findings, Clin Immunol Immunopathol 52: 6884, 1989.
  • 27
    Polk BF, Fox R, Brookmeyer R, Kanchanaraksa S, Kaslow R, Visscher B, Rinaldo CR, Phair JP: Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 316: 6166, 1987.
  • 28
    Reichert T, DeBruyère M, Deneys V, Tötterman T, Lydyard P, Yuksel F, Chapel H, Jewell D, Van Hove L, Linden J, Buchner L: Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol 60: 190208, 1991.
  • 29
    Rickman WJ, Waxdal MJ, Monical C, Damato JD, Burke DS: Department of Army lymphocyte immunophenotyping quality assurance program. Clin Immunol Immunopathol 52: 8595, 1989.
  • 30
    Shah VO, Civin CI, Loken MR: Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. J Immunol 140: 18611867, 1988.
  • 31
    Taylor JMG, Fahey JL, Detels R, Giorgi JV: CD4 percentage, CD4 number and CD4:CD8 ratio in HIV infection: Which to choose and how to use. J Acquir Immune Defic Syndr 2: 134124, 1989.
  • 32
    Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH Jr., Reichman RC, Bartlett JA, Hirsch MS, Murphy RL, Hardy WD, Soeiro R, Fischl MA, Bartlett JG, Merigan TC, Hyslop NE, Richman DD, Valentine FT, Corey L, The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases: Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 322: 941949, 1990.
  • 33
    Waxdal MJ, Monical MC, Fleisher TA, Marti GE: Inter-laboratory survey of lymphocyte immunophenotyping. Pathol Immunopathol Res 7: 345356, 1988.
  • 34
    Wood GS, Warner NL, Warnke RA: Anti-Leu 3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage, J Immunol 131: 212216, 1983.